Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility

Small bowel accounts for only 0.5% of cancer cases in the US but incidence rates have been rising at 2.4% per year over the past decade. One-third of these are adenocarcinomas but little is known about their molecular pathology and no molecular markers are available for clinical use. Using a retrosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Alvi, Muhammad A., McArt, Darragh G., Kelly, Paul, Fuchs, Marc-Aurel, Alderdice, Matthew, McCabe, Clare M., Bingham, Victoria, McGready, Claire, Tripathi, Shailesh, Emmert-Streib, Frank, Loughrey, Maurice B., McQuaid, Stephen, Maxwell, Perry, Hamilton, Peter W., Turkington, Richard, James, Jacqueline A., Wilson, Richard H., Salto-Tellez, Manuel
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper: Pathology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673235/
https://ncbi.nlm.nih.gov/pubmed/26315110
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados